U.S. Oil and Gas Stock News

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...

Wingstop stock has fallen 61.9% over the past year, yet the current checks send mixed signals on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to upside while earnings based multiples screen the shares as expensive. Recent news around soft same store sales and loyalty driven promotions adds another layer to how investors may think about what a fair price for Wingstop looks like today. Wingstop is down 61.9% over the last year, which puts the...

Recently, Stephens & Co. initiated research coverage on H&R Block with an Equal-Weight rating, adding another institutional voice to the tax preparer’s analyst following. This new coverage lands after past strong earnings and guidance raised in May, potentially sharpening investor focus on the company’s defensive profile and relative valuation. Next, we’ll examine how this fresh analyst coverage and heightened visibility may influence H&R Block’s broader investment narrative. Capitalize on...

Inflation, central bank decisions and energy prices are keeping markets on edge, which makes it harder to rely on short term signals. Founder led companies offer a different anchor. These leaders often have reputations, wealth and careers tied directly to the long term outcome of their stock. The Founder-Led Companies screener focuses on this alignment. It does not track a single sector or story, which can help you stay flexible as conditions change. In this article you will see three stocks...

Omega Healthcare Investors has delivered a strong 115.8% total return over the past five years, and the latest valuation work suggests the stock may still trade below an estimate of intrinsic value based on Discounted Cash Flow, rather than looking stretched after that run. A 115.8% return over five years suggests long term holders in Omega Healthcare Investors have already been well rewarded. Any further upside case now rests on whether the current price still leaves a margin against...

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...

Atlassian stock has staged a sharp short term rebound but sits on a long stretch of weak returns, which contrasts with valuation checks that currently lean toward the shares looking cheap on several standard measures. Over the past 5 years, Atlassian has delivered a cumulative decline of 69.4%, which frames today’s share price near US$104 as a recovery off a much lower base rather than a long run success story. Expectations around Atlassian’s ability to convert its software revenue into...

US cybersecurity stocks sit at the crossroads of two powerful forces. On one side are rising concerns about AI being misused in hacks and cross border data theft. On the other are signs that regulators may tighten control of high risk AI tools after recent OpenAI related incidents. That mix can pressure some AI heavy giants while potentially giving select security focused players a relative edge. This article looks at 3 US cybersecurity stocks from the screener that appear closely exposed to...

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the share price has moved further than the fundamentals suggest. The roughly 56.9% decline over the last 12 months means existing shareholders have taken a heavy hit, while potential new buyers are looking at a much lower entry point. The global restructuring plan that targets lower ongoing costs can support valuation over time. However, the...

SiriusPoint Ltd. has reported past second-quarter 2026 results showing revenue of US$744.1 million versus US$748.2 million a year earlier, with net income rising to US$68.6 million and diluted earnings per share from continuing operations increasing to US$0.58 from US$0.50. Despite slightly lower revenue, SiriusPoint delivered higher profitability and has also strengthened its leadership bench with the appointment of a new Chief Operating Officer to drive technology and operational...

AvalonBay Communities has delivered a 15.1% total return over the past 3 years, yet the valuation picture is not straightforward. An intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to upside, while broader checks look more mixed. At the same time, market-based multiples suggest the stock is trading at about the right level, which puts extra focus on which lens investors choose to rely on. Over the last 3 years, AvalonBay Communities has returned 15.1%, which is...

Clorox stock is trading at about US$99.63 after a difficult few years for shareholders, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples currently point to the shares looking inexpensive rather than stretched. Clorox has delivered a decline of roughly 29.1% over the past 5 years, which means the share price has lagged while the latest valuation checks now suggest more supportive pricing. Expectations that Clorox can continue to convert earnings into...

In July 2026, Dynex Capital reported second-quarter 2026 results showing net income of US$180.79 million, with basic and diluted earnings per share from continuing operations of US$0.80. An unusual aspect of these results is that first-half 2026 net income of US$100.43 million trails the second-quarter figure alone, highlighting quarterly volatility. We’ll now consider how this earnings volatility, particularly the stronger second quarter performance, may influence Dynex Capital’s broader...

Varonis Systems walked into this earnings season on a strong run, with the stock up sharply over the past three months. That momentum snapped hard. Shares fell 9% to US$40.65 in the first full session after results, even though the headline was not about a demand problem. The real story is the margin picture. Varonis reported US$180.0m in revenue with a non GAAP gross margin of 77.7% and only a thin non GAAP operating income of US$3.7m. For a high price to sales cyber security stock, that...

Fed Chairman Kevin Warsh’s decision to hold rates steady despite inflation above target has thrown fresh attention on financial stocks that live and breathe interest rate expectations. Longer term yields have moved higher and market odds now lean toward rates staying unchanged at the next meeting. That combination can reshape funding costs, loan demand, investment returns and capital positions for banks and insurers. This article walks through how that backdrop links to our Financial Sector...

TPG RE Finance Trust went into this earnings print with a stock that has drifted lower in recent weeks and then dropped another 3.9% to about US$8.21 as investors reacted. The headline, however, is not about the income statement. It is the balance sheet. Management used the quarter to lock in a US$400 million Term Loan B, add a long dated revolver and extend secured facilities, all while keeping overall funding costs and leverage broadly in line. For a commercial mortgage REIT, that kind of...

Astera Labs stock has delivered a 93.8% return over the past year. After that kind of move, the current valuation now looks closer to fair value, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model and market-based multiples both pointing to pricing that is about in line with fundamentals rather than clearly cheap. Over the last 12 months Astera Labs is up 93.8%, so the share price already reflects a lot of optimism about the company. Expectations for continued revenue...

RenaissanceRe Holdings Ltd. has reported past second-quarter 2026 results, with revenue of US$2,768.6 million and net income of US$663.08 million, alongside six-month diluted earnings per share from continuing operations of US$21.94 that exceeded the prior-year period. Over the same timeframe, the company also completed a substantial share repurchase program of 3,425,600 shares for US$995.69 million, returning a meaningful portion of capital to shareholders while shrinking its equity...

NovoCure stock is coming off a very difficult five year stretch, with the share price down about 90%, yet the latest valuation checks still lean toward the shares looking cheap on several measures. That contrast, alongside fresh company developments in cancer therapies, is what investors are weighing now. Over the past five years, NovoCure shares have declined about 90%. As a result, any sign of a sustainable business recovery can have an outsized impact on how the market prices the...

US LNG exports are reshaping global gas flows, and that shift is starting to show up in individual stocks. As Louisiana grows into a major LNG hub and long term export contracts with Europe expand, some companies appear well placed for higher fee based volumes, while others face pressure from changing trade routes and pricing. This article walks through three stocks exposed to this news, with two that could benefit from the US export build out and one that may face headwinds, to help you...

OPKO Health (OPK) moved into focus after its Q2 2026 earnings report and guidance, which showed revenue of US$163.58 million and a sharply lower net loss compared with the prior year period. See our latest analysis for OPKO Health. OPKO Health shares have been volatile around the earnings release, with the 1-day share price return falling 17.27% after hitting a new 52-week high. However, the 90-day share price return of 24.09% and 1-year total shareholder return of 6.64% suggest momentum has...